静脉注射替加环素有助于在标准治疗失败后治愈严重艰难梭菌感染（CDI）：1例病例报告及替加环素用于CDI的文献综述
Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI.
作者信息
Navalkele Bhagyashri D, Lerner Stephen A
机构信息
Division of Infectious Diseases , Wayne State University School of Medicine, Harper University Hospital , Detroit, Michigan.
出版信息
Open Forum Infect Dis. 2016 May 12;3(2):ofw094. doi: 10.1093/ofid/ofw094. eCollection 2016 Apr.
Abstract
Standard treatment for severe Clostridium difficile infection (CDI) is oral vancomycin with metronidazole. After failure of this standard regimen, treatment becomes challenging. A young woman treated for septic shock developed CDI. Standard treatment failed and she was ineligible for fecal transplant. Addition of tigecycline to her regimen resulted in cure.
摘要
严重艰难梭菌感染（CDI）的标准治疗方法是口服万古霉素加甲硝唑。在这种标准治疗方案失败后，治疗变得具有挑战性。一名因感染性休克接受治疗的年轻女性患上了CDI。标准治疗失败，且她不符合粪便移植的条件。在她的治疗方案中加用替加环素后治愈。
相似文献
1
Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI.
Open Forum Infect Dis. 2016 May 12;3(2):ofw094. doi: 10.1093/ofid/ofw094. eCollection 2016 Apr.
2
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection.
Infect Dis Ther. 2014 Dec;3(2):321-31. doi: 10.1007/s40121-014-0050-x. Epub 2014 Dec 3.
3
The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
Intern Med J. 2018 Jun;48(6):651-660. doi: 10.1111/imj.13742.
4
Tigecycline for the treatment of severe Clostridium difficile infection.
Ann Pharmacother. 2011 Jul;45(7-8):1005-10. doi: 10.1345/aph.1Q080. Epub 2011 Jul 5.
5
Fecal Microbiota Transplantation in Recurrent NAP1/B1/027 Clostridium Difficile Infection (CDI) Resistant to Vancomycin and Metronidazole in a Patient with Ulcerative Colitis (UC): A Case Report.
Rev Med Chir Soc Med Nat Iasi. 2016 Jul-Sep;120(3):563-7.
6
Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Clin Microbiol Infect. 2016 Dec;22(12):990-995. doi: 10.1016/j.cmi.2016.08.017. Epub 2016 Sep 4.
7
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study.
Clin Microbiol Infect. 2018 Feb;24(2):180-184. doi: 10.1016/j.cmi.2017.06.005. Epub 2017 Jun 19.
8
Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.
Antibiotics (Basel). 2015 Jun 19;4(2):216-29. doi: 10.3390/antibiotics4020216.
9
Best strategies in recurrent or persistent Clostridium difficile infection.
Surg Infect (Larchmt). 2011 Jun;12(3):235-9. doi: 10.1089/sur.2010.080. Epub 2011 Jul 18.
10
Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
J Hosp Infect. 2017 Apr;95(4):426-432. doi: 10.1016/j.jhin.2016.12.018. Epub 2016 Dec 29.
引用本文的文献
1
Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study.
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0000122. doi: 10.1128/aac.00001-22. Epub 2022 Jun 1.
2
Novel Antimicrobials for the Treatment of Infection.
Front Med (Lausanne). 2018 Apr 16;5:96. doi: 10.3389/fmed.2018.00096. eCollection 2018.
3
Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Infection?
Open Forum Infect Dis. 2017 Feb 10;4(1):ofw264. doi: 10.1093/ofid/ofw264. eCollection 2017 Winter.
4
A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection.
Infect Dis Ther. 2017 Mar;6(1):1-35. doi: 10.1007/s40121-016-0140-z. Epub 2016 Dec 1.
本文引用的文献
1
Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update.
Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S48-65. doi: 10.1017/s0899823x00193857.
2
Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.
J Antimicrob Chemother. 2015 Jan;70(1):153-9. doi: 10.1093/jac/dku325. Epub 2014 Aug 23.
3
Tigecycline for severe Clostridium difficile infection.
Int J Infect Dis. 2014 Sep;26:171-2. doi: 10.1016/j.ijid.2014.04.025. Epub 2014 Jul 23.
4
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.
Am J Gastroenterol. 2013 Apr;108(4):478-98; quiz 499. doi: 10.1038/ajg.2013.4. Epub 2013 Feb 26.
5
Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin.
Case Rep Med. 2012;2012:702910. doi: 10.1155/2012/702910. Epub 2012 Jul 9.
6
Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.
Clin Infect Dis. 2012 Aug;55 Suppl 2(Suppl 2):S154-61. doi: 10.1093/cid/cis462.
7
Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
Scand J Infect Dis. 2012 Mar;44(3):228-30. doi: 10.3109/00365548.2011.616224. Epub 2011 Nov 13.
8
Intravenous tigecycline in the treatment of severe recurrent Clostridium difficile colitis.
Med J Aust. 2011 Apr 4;194(7):374-5. doi: 10.5694/j.1326-5377.2011.tb03018.x.
9
Failure of tigecycline to treat severe Clostridium difficile infection.
Anaesth Intensive Care. 2010 Jul;38(4):755-8. doi: 10.1177/0310057X1003800339.
10
Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole.
Int J Antimicrob Agents. 2010 Mar;35(3):311-2. doi: 10.1016/j.ijantimicag.2009.11.008. Epub 2009 Dec 31.
Zotero 插件